Evidence for anti-ischemic effect of dual-chamber pacing in patients with the obstructive form of hypertrophic cardiomyopathy

Japanese Heart Journal

Volumn 44, Issue 4, 2003, Pages 587-592

  Mohri, Masahiro ^a   Ichiki, Toshihiro ^a   Kuga, Takeshi ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Coronary circulation; Lactate metabolism; Myocardial ischemia

Indexed keywords

DILTIAZEM; DISOPYRAMIDE; LACTIC ACID; METOPROLOL;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; FEMALE; HEART ATRIUM PACING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PACING; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRESSURE GRADIENT; PRIORITY JOURNAL; QUALITY OF LIFE; CORONARY ARTERY BLOOD FLOW; HEART ATRIUM; HEART MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; FEMALE; HEART ATRIA; HEMODYNAMIC PROCESSES; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 0041735076     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.587     Document Type: Article

References (9)

1. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995; 92: 1680-92.
2. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathies, part I. Circulation 2001; 104: 2113-6.
3. Cannon RO, Schenke WH, Maron BJ, et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1987; 10: 53-62.
4. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-42.
5. Gadler F, Linde C, Daubert C, et al. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. Pacing In Cardiomyopathy (PIC) study group. Eur Heart J 1999; 20: 1044-50.
6. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29: 435-41.
7. Linde C, Gadler F, Kappenberger L, Ryden L, for the PIC Study Group. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. Am J Cardiol 1999; 83: 903-7.
8. Slade AK, Sadoul N, Shapiro L, et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 1996; 75: 44-9.
9. Cannon RO, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985; 71: 234-43.